TherapeuticsMD Inc reports results for the quarter ended in June - Earnings Summary

TherapeuticsMD

14/08/2023 14:32

* TherapeuticsMD Inc  TXMD.OQ  reported a quarterly adjusted
loss
of 24 cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 7 cents per
share.
    * Revenue fell 98.5% to $437.00 thousand from a year ago;
analysts
expected $500.00 thousand. 
    * TherapeuticsMD Inc's reported EPS for the quarter was a
loss
of 24 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * TherapeuticsMD Inc shares had fallen by 3.9% this
quarter and
lost 29.2% so far this year.
    * The company reported a quarterly loss of $2.41 million.
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $5.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.07          -0.24          Missed
 Mar. 31 2023      0.06           -0.37          Missed
 Dec. 31 2022      -1.11          8.23           Beat
 Sep. 30 2022      -0.57          -3.13          Missed